Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516004 · ClinicalTrials.gov registry record · Phase 2
Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning
A Phase 2 study of Keratoconus, sponsored by Cohen Laser and Vision Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05516004: Recruiting Phase 2 study of Keratoconus, sponsored by Cohen Laser and Vision Center.
NCT05516004 is a Phase 2 study of Keratoconus that is actively recruiting participants, run by Cohen Laser and Vision Center. The registered enrollment target is 300 participants, below the 1,166-participant average among 21 other Keratoconus trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05516004, a Phase 2 study of Keratoconus, is actively recruiting participants, sponsored by Cohen Laser and Vision Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study study is to determine the effectiveness of cornea cross linking in patients with Keratoconus or other cornea thinning conditions.
Primary Outcome
As measured by Pentacam tomographer (Oculus)
Conditions Studied
Interventions
- DEVICE PXL Platinum 330 system
Study Locations (1)
Florida
- Cohen Laser and Vision Center - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2034-06-01 |
| Phase | Phase 2 |
What NCT05516004 shows while recruiting
NCT05516004 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,166-participant average among 21 other Keratoconus trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Keratoconus appearing as the primary indexed condition, and to 1 intervention - of which PXL Platinum 330 system is the first listed.
NCT05516004 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05516004 about?
NCT05516004 is a clinical study titled "Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning". This study study is to determine the effectiveness of cornea cross linking in patients with Keratoconus or other cornea thinning conditions.
What is the current status of trial NCT05516004?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2024-07-01. Estimated completion is 2034-06-01.
What conditions does trial NCT05516004 study?
This clinical trial studies the following conditions: Keratoconus.
What interventions are being tested in trial NCT05516004?
The interventions under investigation include: PXL Platinum 330 system (DEVICE).
Who is sponsoring clinical trial NCT05516004?
This trial is sponsored by Cohen Laser and Vision Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05516004 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05516004's enrollment target sits among peer trials
300 8th of 21 higher than 14 of 21 other Keratoconus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Keratoconus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
RECRUITING · Phase 2
-
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
RECRUITING · Phase 2
-
Comparison of Standard vs. Accelerated Corneal Crosslinking
RECRUITING · Phase 2
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
-
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI